Michael Berry, MD
Dermatology · Elmhurst, NYNPI 1962692152
Payments from drug & device makers
What this record shows
Johnson & Johnson accounts for 83.3% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $372 and has fallen 93.2% since, to $25 in 2025. That places this record below the midpoint for dermatology clinicians in NY, where the typical reported total is $2,360.
Across 56 payments — averaging $22.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Regeneron Healthcare Solutions, Inc.$94
- Arcutis Biotherapeutics, Inc.$80
- Cipher Pharmaceuticals US LLC$25
- AbbVie$12
Across 15 payments — averaging $954.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$14K
What the payments were for
- Food & beverage$70956%
- Education$55544%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 48 | $1,052 |
| Regeneron Healthcare Solutions, Inc. | 1 | $94 |
| Arcutis Biotherapeutics, Inc. | 5 | $80 |
| Cipher Pharmaceuticals US LLC | 1 | $25 |
| AbbVie | 1 | $12 |
How this compares
$1,264 in reported general payments places this provider in the 40th percentile of 1,151 dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OpzeluraRuxolitinib Phosphate | 13 | $25,057 |
| Clobetasol Propionate | 311 | $24,531 |
| Halobetasol Propionate | 95 | $6,400 |
| Metronidazole | 71 | $5,172 |
| CiclopiroxCiclopirox Olamine | 120 | $4,457 |
| Tretinoin | 45 | $4,291 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 63 | $4,038 |
| Triamcinolone Acetonide | 339 | $4,023 |
| Mometasone Furoate | 174 | $3,700 |
| Ketoconazole | 209 | $2,753 |
| Clindamycin Phosphate | 74 | $2,660 |
| Ammonium Lactate | 92 | $1,826 |
| Hydrocortisone | 110 | $1,669 |
| Fluocinonide | 23 | $1,471 |
| Fluticasone Propionate | 41 | $916 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Elmhurst
- Huachen WeiElmhurst$252K
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Jeffrey WeinbergKew Gardens$2.3M
- Joshua ZeichnerNew York$2.1M
- Russell CohenOceanside$2.1M
- Jeffrey LaducaAuburn$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.